HIT Consultant March 17, 2023
Marie E. Lamont, Global RWE Data Strategy, Access & Enablement at IQVIA and General Manager

The American Cancer Society’s Cancer Statistics 2023 report highlighted a few major accomplishments within oncology, such as decreased cancer mortality rates and increased trial diversity. However, there is still much work to be done. Especially with the multiple types of new and ongoing challenges clinicians and staff members are facing – such as high turnover rates, decreased budgets and increased feelings of burnout – taking the necessary steps to enhance clinical trial procedures is crucial to the continuous improvement of clinical trials and overall quality of life of cancer patients.

While there is not a “be-all and end-all” solution to these issues, one strategy clinicians can take is the implementation of modern eClinical and precision oncology solutions. These tools can...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Clinical Trials, Provider, Survey / Study, Technology, Trends
LabConnect Agrees to Acquire A4P Consulting
Q&A: Bring your own device: How patients own tech is being used in clinical trials
With $75m cash injection, SynOx plans ph3 rare tumour trial
Outsourcing in Clinical Trials Europe 2024: How technology can continue to propel the clinical trial landscape
FDA Proposes the Establishment of the Center for Clinical Trial Innovation

Share This Article